- Home
- CMCL vs ITOS Comparison
CMCL vs ITOS Comparison
Compare CMCL & ITOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMCL
- ITOS
- Stock Information
- Founded
- CMCL 1992
- ITOS 2011
- Country
- CMCL Jersey
- ITOS United States
- Employees
- CMCL N/A
- ITOS N/A
- Industry
- CMCL Precious Metals
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CMCL Basic Materials
- ITOS Health Care
- Exchange
- CMCL Nasdaq
- ITOS Nasdaq
- Market Cap
- CMCL 310.6M
- ITOS 323.2M
- IPO Year
- CMCL N/A
- ITOS 2020
- Fundamental
- Price
- CMCL $15.54
- ITOS $9.18
- Analyst Decision
- CMCL Buy
- ITOS Strong Buy
- Analyst Count
- CMCL 1
- ITOS 4
- Target Price
- CMCL $13.50
- ITOS $32.50
- AVG Volume (30 Days)
- CMCL 76.7K
- ITOS 692.7K
- Earning Date
- CMCL 11-19-2024
- ITOS 11-15-2024
- Dividend Yield
- CMCL 3.60%
- ITOS N/A
- EPS Growth
- CMCL N/A
- ITOS N/A
- EPS
- CMCL 0.59
- ITOS N/A
- Revenue
- CMCL $159,880,000.00
- ITOS $35,000,000.00
- Revenue This Year
- CMCL $31.50
- ITOS $271.18
- Revenue Next Year
- CMCL $9.45
- ITOS N/A
- P/E Ratio
- CMCL $26.13
- ITOS N/A
- Revenue Growth
- CMCL 23.43
- ITOS N/A
- 52 Week Low
- CMCL $8.91
- ITOS $8.41
- 52 Week High
- CMCL $16.95
- ITOS $18.75
- Technical
- Relative Strength Index (RSI)
- CMCL 53.98
- ITOS 42.13
- Support Level
- CMCL $14.50
- ITOS $8.41
- Resistance Level
- CMCL $15.80
- ITOS $9.64
- Average True Range (ATR)
- CMCL 0.52
- ITOS 0.46
- MACD
- CMCL -0.15
- ITOS 0.20
- Stochastic Oscillator
- CMCL 42.45
- ITOS 54.47
About CMCL Caledonia Mining Corporation Plc
Caledonia Mining Corp PLC is a gold exploration, development, and mining company. The company's segment includes Blanket, South Africa, Bilboes Oxide mine, and E&E projects. The company generates the majority of its revenue from the blanket project. The Blanket Mine is located in the south-west of Zimbabwe and operates at a depth of approximately 750 meters below the surface. The company's project includes Maligreen and Motapa.
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.